International PharmacoVigilance Day

The International Pharmacovigilance Day conference brings together senior leaders and technical experts to discuss the hot topics of today and tomorrow, share learnings and explore solutions. It promises to be a lively exchange of ideas, learning and concepts during a one day and a half, where the topics to be treated, among many others, include:

• How can Patient Support Programs and Risk Management become more patient centered?
• What could be Risk minimization measures and how to be compliant with the quality requirements?
• What opportunities and challenges does the EU Electronic health record bring to PV?
• Preparing for regulatory inspections with new global inspectorates and in post-Brexit?
• Digital Pharmacovigilance: What is hype and what is hot?
• EudraVigilance - new approaches and new challenges
• How are companies expected to fulfil their requirements towards new regulations?
• How the future will look like, and what could be new skills for a new PV future?

These are some of the questions that will make the future of PV, but how to be ready to embrace it?

We warmly welcome you to join us for this event of the future.

Scientific Committee

Jabeen Ahmad - Regional Pharmacovigilance Director, Eastern Europe, Middle East & Africa (EEMEA) at AbbVie 
Marco Anelli - Head of Medical Affairs and Pharmacovigilance Advisory Practice – PLG (Product Life Group)
Raffaele Di Marzo - EU QPPV at Kedrion
Dr. Leonardo Ebeling - Managing Director at Dr. Ebeling & Assoc. GmbH
Martin Holm-Petersen - CEO at Insife
Betina Østergaard Eriksen - Vice President, Safety Surveillance at Novo Nordisk
Solange Corriol-Rohou - Sr. Director Regulatory Affairs & Policy, Europe at AstraZeneca